STOCK TITAN

Eloxx (ELOX) 10% holder swaps Pre-Funded Warrants into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Eloxx Pharmaceuticals, Inc. reported that 10% owner Domicilium Real Estate Fund III LP, through affiliated investment entities, restructured its position in pre-funded warrants and common stock. Several transactions coded "J" as "other acquisition or disposition" reflect exchanges of Pre-Funded Warrants into common shares pursuant to their terms.

Footnotes state that each Pre-Funded Warrant was exchanged for one share of Eloxx common stock and that the warrants have no expiration date and are exercisable at any time, subject to a 19.99% beneficial ownership cap. All holdings are reported as indirect, through funds and LLCs advised by Domicilium and managed by Daniel Simon. No open-market purchases or sales are reported in this filing.

Positive

  • None.

Negative

  • None.
Insider Domicilium Real Estate Fund III LP
Role null
Type Security Shares Price Value
Other Pre-funded Warrant 238,422 $0.00 --
Other Pre-funded Warrant 361,578 $0.00 --
Other common stock, $0.01 par value per share 238,422 $0.00 --
Other common stock, $0.01 par value per share 361,578 $0.00 --
holding Pre-funded Warrant -- -- --
holding Pre-funded Warrant -- -- --
holding common stock, $0.01 par value per share -- -- --
Holdings After Transaction: Pre-funded Warrant — 0 shares (Indirect, See footnote); common stock, $0.01 par value per share — 238,422 shares (Indirect, See footnote)
Footnotes (1)
  1. Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock. The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner. The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium. The securities may be deemed to be indirectly beneficially owned by (i) Domicilium, and (ii) Daniel Simon, the managing member of Domicilium. The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. The securities are owned directly by MSEK Charleston LLC ("MSEK") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to MSEK, and (ii) Daniel Simon, the managing member of Domicilium. The securities are owned directly by Bold Stroke Investments, LLC ("Bold Stroke") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to Bold Stroke, and (ii) Daniel Simon, the managing member of Domicilium.
Common stock transaction 1 361,578 shares Transaction code J, common stock, indirect ownership
Common stock transaction 2 238,422 shares Transaction code J, common stock, indirect ownership
Beneficial ownership cap 19.99% Maximum common stock beneficial ownership after warrant exercise
Warrant exercise price $0.0000 per share Pre-Funded Warrants underlying common stock
Indirect common stock holding 14,285 shares Common stock, indirect, holding entry after transaction
Pre-Funded Warrants financial
"Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged..."
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficially owned financial
"The securities are owned directly by Domicilium Real Estate Fund III LP ... and may be deemed to be indirectly beneficially owned..."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
ten percent owner financial
""is_ten_percent_owner": 1"
exercise price financial
""conversion_or_exercise_price": "0.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
indirect ownership financial
""ownership_type": "indirect""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Domicilium Real Estate Fund III LP

(Last)(First)(Middle)
535 S. KIMBALL AVE, SUITE 140

(Street)
SOUTHLAKE TEXAS 76092

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Eloxx Pharmaceuticals, Inc. [ ELOX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
common stock, $0.01 par value per share06/10/2026J(1)238,422A(1)238,422ISee footnote(2)
common stock, $0.01 par value per share06/10/2026J(1)361,578A(1)361,578ISee footnote(3)
common stock, $0.01 par value per share14,285ISee footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Pre-funded Warrant(5)06/10/2026J(1)238,422 (5) (5)common stock, $0.01 par value per share238,422(5)0ISee footnote(2)
Pre-funded Warrant(5)06/10/2026J(1)361,578 (5) (5)common stock, $0.01 par value per share361,578(5)834,489ISee footnote(3)
Pre-funded Warrant(5) (5) (5)common stock, $0.01 par value per share0361,578ISee footnote(6)
Pre-funded Warrant(5) (5) (5)common stock, $0.01 par value per share0611,317ISee footnote(7)
Explanation of Responses:
1. Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.
2. The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.
3. The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium.
4. The securities may be deemed to be indirectly beneficially owned by (i) Domicilium, and (ii) Daniel Simon, the managing member of Domicilium.
5. The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
6. The securities are owned directly by MSEK Charleston LLC ("MSEK") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to MSEK, and (ii) Daniel Simon, the managing member of Domicilium.
7. The securities are owned directly by Bold Stroke Investments, LLC ("Bold Stroke") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to Bold Stroke, and (ii) Daniel Simon, the managing member of Domicilium.
Remarks:
Domicilium Capital Partners LLC, Domicilium Real Estate Fund III GP LLC, Daniel Simon, BKJLAGG, LLC, MSEK Charleston LLC and Bold Stroke Investments, LLC will be reported as a Reporting Person on a subsequent Form 4 once CIK codes are received. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Domicilium Real Estate Fund III LP, By: Domicilium Real Estate Fund III GP LLC, its General Partner, By: /s/ Daniel Simon, Managing Member06/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did Domicilium Real Estate Fund III LP report for ELOX?

Domicilium Real Estate Fund III LP reported restructuring transactions coded "J" involving Pre-Funded Warrants and Eloxx common stock. Footnotes explain that each Pre-Funded Warrant was exchanged for one share of common stock, with no open-market buying or selling disclosed.

Did the ELOX Form 4 show any open-market buys or sells by the insider?

The Form 4 shows no open-market purchases or sales. All transactions are coded "J" as "other acquisition or disposition," reflecting exchanges and restructurings between Pre-Funded Warrants and common stock held through investment entities rather than direct market trades.

How many Eloxx common shares were involved in the restructuring transactions?

The filing reports two "J" transactions in Eloxx common stock for 361,578 shares and 238,422 shares, respectively. These correspond to related "J" transactions in Pre-Funded Warrants, reflecting exchanges pursuant to the warrant terms rather than cash purchases or market sales.

What are the key terms of the Eloxx Pre-Funded Warrants held by the insider?

The Pre-Funded Warrants have no expiration date and are exercisable at any time after issuance. However, a holder cannot exercise if, after exercise, it would beneficially own more than 19.99% of Eloxx’s outstanding common stock, limiting potential concentration.